HC Wainwright Forecasts Immix Biopharma Q1 Earnings
Immix Biopharma, Inc. (NASDAQ:IMMX – Free Report) – Equities researchers at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Immix Biopharma in a note issued to investors on Wednesday, June 4th. HC Wainwright analyst R. Burns forecasts that the company will post earnings of ($0.14) per share for the quarter. HC […]
